A Phase I/II Study of ABT-888 in Combination With 5-fluorouracil and Oxaliplatin (Modified FOLFOX-6) in Patients With Metastatic Pancreatic Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Veliparib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions
- 13 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Dec 2016 Planned number of patients changed from 48 to 79.
- 12 Feb 2014 According to NCT record; planned end date changed from 1 Dec 2014 to 1 Dec 2017.